Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation
- PMID: 32305667
- PMCID: PMC7485580
- DOI: 10.1016/j.cellsig.2020.109637
Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation
Abstract
Polycystin-1, whose mutation is the most frequent cause of autosomal dominant polycystic kidney disease, is an extremely large and multi-faceted membrane protein whose primary or proximal cyst-preventing function remains undetermined. Accumulating evidence supports the idea that modulation of cellular signaling by heterotrimeric G proteins is a critical function of polycystin-1. The presence of a cis-autocatalyzed, G protein-coupled receptor (GPCR) proteolytic cleavage site, or GPS, in its extracellular N-terminal domain immediately preceding the first transmembrane domain is one of the notable conserved features of the polycystin-1-like protein family, and also of the family of cell adhesion GPCRs. Adhesion GPCRs are one of five families within the GPCR superfamily and are distinguished by a large N-terminal extracellular region consisting of multiple adhesion modules with a GPS-containing GAIN domain and bimodal functions in cell adhesion and signal transduction. Recent advances from studies of adhesion GPCRs provide a new paradigm for unraveling the mechanisms by which polycystin-1-associated G protein signaling contributes to the pathogenesis of polycystic kidney disease. This review highlights the structural and functional features shared by polycystin-1 and the adhesion GPCRs and discusses the implications of such similarities for our further understanding of the functions of this complicated protein.
Keywords: ADPKD; Cell adhesion; GAIN domain; GPS; Heterotrimeric G protein.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Figures
Similar articles
-
The GPCR properties of polycystin-1- A new paradigm.Front Mol Biosci. 2022 Nov 4;9:1035507. doi: 10.3389/fmolb.2022.1035507. eCollection 2022. Front Mol Biosci. 2022. PMID: 36406261 Free PMC article. Review.
-
Matching structure with function: the GAIN domain of adhesion-GPCR and PKD1-like proteins.Trends Pharmacol Sci. 2013 Aug;34(8):470-8. doi: 10.1016/j.tips.2013.06.002. Epub 2013 Jul 11. Trends Pharmacol Sci. 2013. PMID: 23850273 Review.
-
A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.Cell Signal. 2020 Aug;72:109634. doi: 10.1016/j.cellsig.2020.109634. Epub 2020 Apr 10. Cell Signal. 2020. PMID: 32283256 Free PMC article. Review.
-
The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus.Elife. 2020 Nov 9;9:e60684. doi: 10.7554/eLife.60684. Elife. 2020. PMID: 33164752 Free PMC article.
-
A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis.EMBO J. 2012 Mar 21;31(6):1364-78. doi: 10.1038/emboj.2012.26. Epub 2012 Feb 14. EMBO J. 2012. PMID: 22333914 Free PMC article.
Cited by
-
Functional impact of intramolecular cleavage and dissociation of adhesion G protein-coupled receptor GPR133 (ADGRD1) on canonical signaling.J Biol Chem. 2021 Jan-Jun;296:100798. doi: 10.1016/j.jbc.2021.100798. Epub 2021 May 20. J Biol Chem. 2021. PMID: 34022221 Free PMC article.
-
Mechanism of tethered agonist-mediated signaling by polycystin-1.Proc Natl Acad Sci U S A. 2022 May 10;119(19):e2113786119. doi: 10.1073/pnas.2113786119. Epub 2022 May 6. Proc Natl Acad Sci U S A. 2022. PMID: 35522707 Free PMC article.
-
ELTD1 is present in extracellular vesicles derived from endothelial cells as a cleaved extracellular domain which induces in vivo angiogenesis.J Extracell Biol. 2022 Aug 2;1(8):e52. doi: 10.1002/jex2.52. eCollection 2022 Aug. J Extracell Biol. 2022. PMID: 38939053 Free PMC article.
-
c-JUN n-Terminal Kinase (JNK) Signaling in Autosomal Dominant Polycystic Kidney Disease.J Cell Signal. 2022;3(1):62-78. doi: 10.33696/Signaling.3.068. J Cell Signal. 2022. PMID: 35253003 Free PMC article.
-
Activation of Polycystin-1 Signaling by Binding of Stalk-derived Peptide Agonists.bioRxiv [Preprint]. 2024 Jul 10:2024.01.06.574465. doi: 10.1101/2024.01.06.574465. bioRxiv. 2024. Update in: Elife. 2024 Oct 07;13:RP95992. doi: 10.7554/eLife.95992 PMID: 38260358 Free PMC article. Updated. Preprint.
References
-
- Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet. 1999;353(9147):103–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
